Medindia

X

China Medical Technologies Announces Shareholder Resolution Adopted at its Annual General Meeting Held on November 16, 2009

Tuesday, November 17, 2009 General News J E 4
Advertisement
BEIJING, Nov. 17 China Medical Technologies,Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical devicecompany that develops, manufactures and markets advanced in-vitro diagnosticproducts, today announced shareholder resolution adopted at its annual generalmeeting of shareholders held in Beijing on November 16, 2009.

At the annual general meeting, the Company's shareholders approved theChina Medical Technologies, Inc. 2009 Equity Incentive Plan (the "2009 Plan")as adopted by the Company's board of directors and proposed for shareholders'approval by the Company. The terms of the 2009 Plan can be found in theCompany's Form 6-K furnished to the U.S. Securities and Exchange Commission(the "SEC") on November 17, 2009, which can be accessed on the Company'sInvestor Relations website at http://ir.chinameditech.com and on the SEC'swebsite at http://www.sec.gov . The Company's shareholders did not adopt anyother resolution at the annual general meeting.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device companythat develops, manufactures and markets advanced in-vitro diagnostic (IVD)products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent insitu Hybridization (FISH) technology and Surface Plasmon Resonance (SPR)technology to detect and monitor various diseases and disorders. For moreinformation, please visit http://www.chinameditech.com .For more information, please contact: Winnie Yam Tel: +852-2511-9808 Email: IR@chinameditech.com

SOURCE China Medical Technologies, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
SOKO Retains The Piacente Group as Strategic Inves...
S
Physicians Urge FDA to Justify Condemnation of E-C...